(Q63336830)
Statements
Cognition (English)
0 references
A 18-month, Open-label, Rater-blinded, Randomized, Multi-center, Active-controlled, Parallel-group Pilot Study to Assess Efficacy and Safety of Fingolimod in Comparison to Interferon Beta 1b in Treating the Cognitive Symptoms Associated to Relapsing-remitting Multiple Sclerosis and to Assess Possible Relationship of These Effects to Regional Brain Atrophy (English)
0 references
May 2011
0 references
September 2015
0 references
151
0 references
18 year
0 references
50 year
0 references